News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current RUBY market cap is 7.5M. The company's latest EPS is USD -1.9875 and P/E is -0.04.
| Quarter End | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -53.73M | -50.86M | -42.91M | -61.58M | -23.1M |
| Net Income | -55.02M | -52.41M | -44.24M | -62.87M | -20.14M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -91.66M | -169.6M | -166.45M | -194.62M | -178.45M |
| Net Income | -89.2M | -163.46M | -167.73M | -196.55M | -179.67M |
| Quarter End | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 318.02M | 267.12M | 229.08M | 170.7M | 23.07M |
| Total Liabilities | 139.24M | 132.47M | 133.54M | 134.11M | 7.94M |
| Total Equity | 178.78M | 134.65M | 95.54M | 36.59M | 15.13M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 479.11M | 394.84M | 277.79M | 318.02M | 23.07M |
| Total Liabilities | 86.1M | 120.63M | 136.23M | 139.24M | 7.94M |
| Total Equity | 393.01M | 274.21M | 141.56M | 178.78M | 15.13M |
| Quarter End | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -145.12M | -47.14M | -81.42M | -117.63M | -150.14M |
| Investing | 81.35M | -80.85M | -82.61M | -4.73M | 12.94M |
| Financing | 198.45M | 76k | 232k | 232k | -75.47M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -58.34M | -110.44M | -127.65M | -145.12M | -150.14M |
| Investing | -111.64M | -132.64M | 100.43M | 81.35M | 12.94M |
| Financing | 374.83M | 27.29M | 26.48M | 198.45M | -75.47M |
| Market Cap | 7.5M |
| Price to Earnings Ratio | -0.04 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.49 |
| Price to Book Ratio | 0.48 |
| Dividend Yield | - |
| Shares Outstanding | 90.4M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -59.21% |
| 52 Week High | 0.42 |
| 52 Week Low | 0.083 |
| Spread (Intraday) | 0 (0.67%) |
| Company Name | Rubius Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.rubiustx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
